Your institution may have access to this item. Find your institution then sign in to continue.
Title
Persistence with weekly alendronate therapy among postmenopausal women.
Authors
Lo, J C; Pressman, A R; Omar, M A; Ettinger, B
Abstract
Although clinical trials indicate that oral bisphosphonates reduce osteoporotic fracture risk, compliance with bisphosphonate therapy in practice is suboptimal, with 1-year discontinuation rates exceeding 50%.
Publication
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2006, Vol 17, Issue 6, p922